OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

KEYCORP /NEW/ (KEY-PL) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

KEY-PL · KEYCORP /NEW/

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 40 filings · fetched 2026-11-13T18:20:21Z

Recent reported activity

0purchase rows on this page
2sale rows on this page
49matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-10-30Filed 2026-11-02Paine Andrew J IIIOfficer · Head of Institutional Bank
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reported as of October 28, 2026.

References:

G GiftCommon Shares · Non-derivative4,265D0IndirectBy spouseForm 4 ↗0001669883-26-000005
2026-10-28Filed 2026-11-02AmendmentPaine Andrew J IIIOfficer · Head of Institutional Bank
Filing context

Amendment: compare with original; not an additional trade.

F1 The Form 4 filed by the reporting person on October 29, 2026, inadvertently omitted an additional gift of shares effected on October 28, 2026.

References: F1

G GiftCommon Shares · Non-derivative7,555D0DirectForm 4/A ↗0001669883-26-000004
2026-10-28Filed 2026-10-29Paine Andrew J IIIOfficer · Head of Institutional Bank
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 On March 16, 2026, the reporting person contributed 50,630 directly owned shares of KeyCorp common stock to a grantor retained annuity trust for the benefit of himself and his children. On April 23, 2026, 19,684 shares from a separate grantor retained annuity trust were returned to the reporting person as directly owned. Upon termination of a separate grantor retained annuity trust, 11,956 shares of KeyCorp common stock were transferred to the reporting person's children. The remaining shares in such trust were returned to the reporting person and are reported in this Form 4 as directly owned.

F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.21.

F3 The reporting person may provide to KeyCorp, any security holder of KeyCorp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F4 Reported as of October 28, 2026.

F5 This option vested in four equal annual installments ending on February 17, 2021.

References: F5

M Exercise / conversionOption to Buy · Derivative39,130D0DirectForm 4 ↗0001669883-26-000003
2026-10-28Filed 2026-10-29Paine Andrew J IIIOfficer · Head of Institutional Bank
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 On March 16, 2026, the reporting person contributed 50,630 directly owned shares of KeyCorp common stock to a grantor retained annuity trust for the benefit of himself and his children. On April 23, 2026, 19,684 shares from a separate grantor retained annuity trust were returned to the reporting person as directly owned. Upon termination of a separate grantor retained annuity trust, 11,956 shares of KeyCorp common stock were transferred to the reporting person's children. The remaining shares in such trust were returned to the reporting person and are reported in this Form 4 as directly owned.

F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.21.

F3 The reporting person may provide to KeyCorp, any security holder of KeyCorp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F4 Reported as of October 28, 2026.

F5 This option vested in four equal annual installments ending on February 17, 2021.

References: F2, F3

S Sale (market/private)Common Shares · Non-derivative39,130D21.2DirectForm 4 ↗0001669883-26-000003
2026-10-28Filed 2026-10-29Paine Andrew J IIIOfficer · Head of Institutional Bank
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 On March 16, 2026, the reporting person contributed 50,630 directly owned shares of KeyCorp common stock to a grantor retained annuity trust for the benefit of himself and his children. On April 23, 2026, 19,684 shares from a separate grantor retained annuity trust were returned to the reporting person as directly owned. Upon termination of a separate grantor retained annuity trust, 11,956 shares of KeyCorp common stock were transferred to the reporting person's children. The remaining shares in such trust were returned to the reporting person and are reported in this Form 4 as directly owned.

F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.21.

F3 The reporting person may provide to KeyCorp, any security holder of KeyCorp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F4 Reported as of October 28, 2026.

F5 This option vested in four equal annual installments ending on February 17, 2021.

References: F1

M Exercise / conversionCommon Shares · Non-derivative39,130A18.96DirectForm 4 ↗0001669883-26-000003
2026-10-27Filed 2026-10-29Paine Andrew J IIIOfficer · Head of Institutional Bank
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 On March 16, 2026, the reporting person contributed 50,630 directly owned shares of KeyCorp common stock to a grantor retained annuity trust for the benefit of himself and his children. On April 23, 2026, 19,684 shares from a separate grantor retained annuity trust were returned to the reporting person as directly owned. Upon termination of a separate grantor retained annuity trust, 11,956 shares of KeyCorp common stock were transferred to the reporting person's children. The remaining shares in such trust were returned to the reporting person and are reported in this Form 4 as directly owned.

F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.21.

F3 The reporting person may provide to KeyCorp, any security holder of KeyCorp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F4 Reported as of October 28, 2026.

F5 This option vested in four equal annual installments ending on February 17, 2021.

References: F1

G GiftCommon Shares · Non-derivative11,956D0IndirectBy GRATForm 4 ↗0001669883-26-000003
2026-10-01Filed 2026-10-02Snyder Barbara RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan.

F2 Includes approximately 133 common shares acquired through dividend reinvestments in September 2026.

F3 Each deferred share is the economic equivalent of one common share.

F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025.

F5 Includes approximately 80 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in September 2026.

F6 Includes approximately 1,417 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan in September 2026.

References: F3, F6

M Exercise / conversionDeferred Shares · Derivative1,417D0DirectForm 4 ↗0001496583-26-000007
2026-10-01Filed 2026-10-02Snyder Barbara RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan.

F2 Includes approximately 133 common shares acquired through dividend reinvestments in September 2026.

F3 Each deferred share is the economic equivalent of one common share.

F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025.

F5 Includes approximately 80 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in September 2026.

F6 Includes approximately 1,417 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan in September 2026.

References: F1, F4, F5

M Exercise / conversionDeferred Shares · Derivative1,526D—DirectForm 4 ↗0001496583-26-000007
2026-10-01Filed 2026-10-02Snyder Barbara RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan.

F2 Includes approximately 133 common shares acquired through dividend reinvestments in September 2026.

F3 Each deferred share is the economic equivalent of one common share.

F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025.

F5 Includes approximately 80 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in September 2026.

F6 Includes approximately 1,417 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan in September 2026.

References: F3

M Exercise / conversionCommon Shares · Non-derivative1,417A—DirectForm 4 ↗0001496583-26-000007
2026-10-01Filed 2026-10-02Snyder Barbara RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan.

F2 Includes approximately 133 common shares acquired through dividend reinvestments in September 2026.

F3 Each deferred share is the economic equivalent of one common share.

F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025.

F5 Includes approximately 80 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in September 2026.

F6 Includes approximately 1,417 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan in September 2026.

References: F1, F2

M Exercise / conversionCommon Shares · Non-derivative1,526A—DirectForm 4 ↗0001496583-26-000007
2026-09-30Filed 2026-10-02Rankin Devina ADirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.

F2 Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2029, or the death of the participant.

F3 Includes approximately 862 dividend-equivalent deferred shares accrued under the Deferred Share Plan in September 2026.

References: F1, F2, F3

A Award / grantDeferred Shares · Derivative1,557A0DirectForm 4 ↗0001557267-26-000006
2026-09-30Filed 2026-10-02Hayes RobinDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.

F2 Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2030, or the death of the participant.

F3 Includes approximately 498 dividend-equivalent deferred shares accrued under the Deferred Share Plan in September 2026.

References: F1, F2, F3

A Award / grantDeferred Shares · Derivative1,557A0DirectForm 4 ↗0001443147-26-000007
2026-09-30Filed 2026-10-02VASOS TODD JDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.

F2 Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of July 1, 2028, or the death of the participant.

F3 Includes approximately 478 dividend-equivalent deferred shares accrued under the Deferred Share Plan in September 2026.

References: F1, F2, F3

A Award / grantDeferred Shares · Derivative1,930A0DirectForm 4 ↗0001243183-26-000006
2026-09-30Filed 2026-10-02CUTLER ALEXANDER MDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Directors may elect to defer the payment of directors' fees into the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp 2026 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.

F2 Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of July 1, 2027, or the death of the participant.

F3 Includes approximately 374 dividend-equivalent deferred shares accrued under the Deferred Share Plan in September 2026.

References: F1, F2, F3

A Award / grantDeferred Shares · Derivative840A0DirectForm 4 ↗0001188585-26-000006
2026-09-21Filed 2026-09-23Gorman Christopher M.Director · Officer · Chairman and CEO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Upon termination of this grantor retained annuity trust on September 21, 2026, 29,821 shares of KeyCorp common stock were transferred to the reporting person's children. The remaining shares in such trust were returned to the reporting person and continue to be reported in this Form 4 as directly owned.

F2 Includes approximately 191 common shares acquired under the KeyCorp Second Amended and Restated Discounted Stock Purchase Plan since March 2026.

F3 These shares are held in a grantor retained annuity trust for the benefit of the reporting person and the reporting person's children. The reporting person is the trustee of the trust.

F4 Reported as of September 22, 2026.

References: F1

G GiftCommon Shares · Non-derivative29,821D0IndirectBy GRATForm 4 ↗0001486643-26-000002
2026-07-22Filed 2026-07-24Ramani MohitOfficer · Chief Risk Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Includes approximately 1,067 common shares acquired through dividend reinvestments between March and June 2026.

References: F1

S Sale (market/private)Common Shares · Non-derivative25,000D22.74DirectForm 4 ↗0002053125-26-000003
2026-07-07Filed 2026-07-07BANK OF NOVA SCOTIADirector · Ten-percent owner
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Disposition pursuant to the Investment Agreement by and between the Reporting Person and the Issuer, dated August 12, 2024 (the "Investment Agreement"), and related arrangements between the Reporting Person and the Issuer, pursuant to which the Reporting Person participates (in certain circumstances, automatically), on a pro rata basis, in any repurchase by the Issuer of its common shares.

Solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person may be deemed to be a director-by-deputization by virtue of the Reporting Person's contractual right to nominate directors to the board of directors of the Issuer pursuant to the Investment Agreement.

References: F1

D Other reported codeCommon Shares · Non-derivative176,803D23.18DirectForm 4 ↗0000950157-26-000788
2026-07-01Filed 2026-07-06Snyder Barbara RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan.

F2 Includes approximately 126 common shares acquired through dividend reinvestments in June 2026.

F3 Each deferred share is the economic equivalent of one common share.

F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025.

F5 Includes approximately 82 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in June 2026.

F6 Includes approximately 1,542 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2026 Equity Compensation Plan in June 2026.

References: F3, F6

M Exercise / conversionDeferred Shares · Derivative20,168D0DirectForm 4 ↗0001496583-26-000006
2026-07-01Filed 2026-07-06Snyder Barbara RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan.

F2 Includes approximately 126 common shares acquired through dividend reinvestments in June 2026.

F3 Each deferred share is the economic equivalent of one common share.

F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025.

F5 Includes approximately 82 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in June 2026.

F6 Includes approximately 1,542 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2026 Equity Compensation Plan in June 2026.

References: F1, F4, F5

M Exercise / conversionDeferred Shares · Derivative1,526D—DirectForm 4 ↗0001496583-26-000006
2026-07-01Filed 2026-07-06Snyder Barbara RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan.

F2 Includes approximately 126 common shares acquired through dividend reinvestments in June 2026.

F3 Each deferred share is the economic equivalent of one common share.

F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025.

F5 Includes approximately 82 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in June 2026.

F6 Includes approximately 1,542 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2026 Equity Compensation Plan in June 2026.

References: F3

M Exercise / conversionCommon Shares · Non-derivative20,168A—DirectForm 4 ↗0001496583-26-000006
2026-07-01Filed 2026-07-06Snyder Barbara RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Prior to 2014, directors were permitted to defer the payment of directors' fees into the KeyCorp Second Directors' Deferred Compensation Plan ("Deferred Compensation Plan"). The deferred fees were converted to deferred shares, which are the economic equivalent of common shares. These deferred shares are being distributed as common shares pursuant to the terms of the Deferred Compensation Plan.

F2 Includes approximately 126 common shares acquired through dividend reinvestments in June 2026.

F3 Each deferred share is the economic equivalent of one common share.

F4 These deferred shares will distribute in ten quarterly installments beginning on July 1, 2025.

F5 Includes approximately 82 dividend-equivalent deferred shares accrued under the Deferred Compensation Plan in June 2026.

F6 Includes approximately 1,542 dividend-equivalent deferred shares accrued under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2026 Equity Compensation Plan in June 2026.

References: F1, F2

M Exercise / conversionCommon Shares · Non-derivative1,526A—DirectForm 4 ↗0001496583-26-000006
2026-07-01Filed 2026-07-06VASOS TODD JDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each deferred share is the economic equivalent of one common share.

References: F1

M Exercise / conversionDeferred Shares · Derivative27,385D0DirectForm 4 ↗0001243183-26-000005
2026-07-01Filed 2026-07-06VASOS TODD JDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each deferred share is the economic equivalent of one common share.

References: F1

M Exercise / conversionCommon Shares · Non-derivative27,385A—DirectForm 4 ↗0001243183-26-000005
2026-07-01Filed 2026-07-06CUTLER ALEXANDER MDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each deferred share is the economic equivalent of one common share.

References: F1

M Exercise / conversionDeferred Shares · Derivative26,893D0DirectForm 4 ↗0001188585-26-000005
2026-07-01Filed 2026-07-06CUTLER ALEXANDER MDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each deferred share is the economic equivalent of one common share.

References: F1

M Exercise / conversionCommon Shares · Non-derivative26,893A—DirectForm 4 ↗0001188585-26-000005

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.